NL-OMON26432已完成不适用
Open, randomized trial of the effect of aripiprazole versus risperidone on social cognition in schizophrenia.
Bristol Meijers Squibb0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. DSM-IV based diagnosis of schizophrenia;
- •2. Age 18 - 50;
排除标准
- •1. Pregnancy;
- •2. Lactation;
研究者
相似试验
已完成
不适用
Open, randomised trial of the effect of aripiprazole versus risperidone on social cognition in schizophreniaSchizophreniaISRCTN61441186niversity Medical Centre Utrecht (UMCU) (The Netherlands)80
已完成
3 期
VERBATIM: A randomised controlled trial of aripiprazole for the treatment of auditory verbal hallucinations in borderline personality disorderBorderline personality disorderACTRN12616001192471Orygen78
已完成
3 期
A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric PracticesSchizophreniaNCT00237939Otsuka Pharmaceutical Development & Commercialization, Inc.1,200
已完成
3 期
Study of Aripiprazole in Patients With Acute Bipolar ManiaBipolar DisorderNCT00097266Otsuka Pharmaceutical Development & Commercialization, Inc.615
已完成
2 期
An Open-Label Trial of Aripiprazole in Autism Spectrum DisordersAsperger's DisorderAutismPervasive Developmental DisorderNCT00308074Cambridge Health Alliance14